MELANIE WATKINS: Open Payments
NPI 1184478695 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 173 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $1,168 · 2025 $2,944
Food & beverage: $2,944
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $386 |
| Novo Nordisk Inc | 18 | $299 |
| AstraZeneca Pharmaceuticals LP | 14 | $268 |
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $250 |
| ABBVIE INC. | 20 | $241 |
| Lilly USA, LLC | 9 | $150 |
| Lundbeck LLC | 10 | $141 |
| Janssen Pharmaceuticals, Inc | 8 | $135 |
| Sumitomo Pharma America, Inc. | 6 | $105 |
| GlaxoSmithKline, LLC. | 5 | $101 |
Products named: REXULTI, Kerendia, Ozempic, VRAYLAR, FARXIGA, SPRAVATO, MOUNJARO, BREZTRI.
Industry payments across TX — which companies pay providers there.
